Acyclovir

Product NDC: 55700-835
11-digit product format: 557000835
Labeler code: 55700
Product ID: 55700-835_9aede090-2c57-4007-80f3-f432b99dbc78
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: Quality Care Products, LLC
Application: ANDA075382
Marketing category: ANDA
Marketing start: 2020-01-03
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 800 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55700-835-35	2024-11-20	C162847	48780-1	1030e365-6d7c-111a-e063-dadaa90a10e2	dba0e70d-466f-42e5-9882-ef62f65b0c61
55700-835-35	2024-01-30	C162847	48780-1	1030e365-6d7c-111a-e063-dadaa90a10e2	dba0e70d-466f-42e5-9882-ef62f65b0c61

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55700-835-35	55700083535	35 TABLET in 1 BOTTLE, PLASTIC (55700-835-35)	35 tablet	2020-01-03	0000-00-00	No	No	Current